Novel evaluation scale for QOL (QOL-ACD-BP) in preoperative chemotherapy for breast cancer

Journal of Cancer Research and Clinical Oncology
Koji TakadaMasaichi Ohira

Abstract

Quality-of-life (QOL) has been reported to affect the prognosis of many types of cancer, and several studies used various QOL assessment tools to determine the relationship between QOL and cancer prognosis. In this study, QOL-Questionnaire for Cancer Patients Treated with Anti-Cancer Drugs-the Breast (QOL-ACD-B) was modified to be suitable for preoperative chemotherapy (POC) and was named the QOL-ACD-BP. A total of 300 patients were treated with POC after being diagnosed with breast cancer between February 2007 and December 2016 at our institute. We evaluated novel evaluation scale for QOL (QOL-ACD-BP) before and after POC in a retrospective manner. In the multivariate analysis with overall survival, the high QOL before [p = 0.048, hazard ratio (HR) 0.441] or after POC (p = 0.030, HR 0.273) was an independent factor. Our study shows that QOL after POC may also affect prognosis and supported the importance of maintaining QOL in cancer treatment. In patients with breast cancer treated with POC, QOL-ACD-BP, which is a new QOL evaluation index, was found to be a useful tool for predicting the patients' prognosis.

References

Dec 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A CoatesJ F Forbes
Jul 1, 1989·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·S KaasaE Lund
Mar 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D F CellaJ Brannon
Aug 10, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J A KramerR Paridaens
Jul 2, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·N R MaiseyD Cunningham
Oct 10, 2002·The Lancet Oncology·Andrew Bottomley, Patrick Therasse
Jun 27, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M-L LuomaC Blomqvist
Feb 3, 2005·Journal of the National Cancer Institute·Davide MauriJohn P A Ioannidis
Sep 21, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lisa M McShaneUNKNOWN Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics
Apr 20, 2007·The Cochrane Database of Systematic Reviews·J S D MieogC J H van de Velde
Jan 30, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carolyn C GotayFabio Efficace
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
May 14, 2009·Journal of the National Cancer Institute·Maggie C U CheangTorsten O Nielsen
Apr 15, 2010·British Journal of Cancer·C K LeeUNKNOWN Australian New Zealand Breast Cancer Trials Group
Jun 29, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A GoldhirschUNKNOWN Panel members
Aug 16, 2011·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Takeru ShiroiwaToru Watanabe
Jun 14, 2014·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Shoko OtsukaReiko Shimojima
Apr 19, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D HowellJ Liberty
Oct 27, 2015·BMC Surgery·Shinichiro KashiwagiKosei Hirakawa

❮ Previous
Next ❯

Citations

Apr 7, 2020·Journal of Translational Medicine·Koji TakadaMasaichi Ohira

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Software Mentioned

JMP
SAS
QOL
ACD

Related Concepts

Related Feeds

Breast Cancer: Therapeutic Approaches

Several different therapeutic approaches are used to treat breast cancer. These include chemotherapy, hormonal therapy, targeted therapy, and Immunotherapy. Discover the latest research on breast cancer therapeutic approaches here.